M&A
Allergan nabs 'double chin' drug in $2.1bn acquisition
Cosmetic pharmaceutical company Allergan will acquire a drug that gets rid of double chin in a $2. 1bn deal to buy Kythera, the company announced.
UnitedHealth tables bid for Aetna
US health insurer UnitedHealth launched a takeover offer overnight for rival Aetna, in a deal that would likely be valued at more than $40, the Wall Street Journal reported on Tuesday citing people familiar with the matter.
Coty reportedly nears deal to buy Procter & Gamble businesses
US company Coty, which owns cosmetics brand Rimmel, has reportedly won auctions to buy three businesses from Procter & Gamble for as much as $12bn.
Cigna to reject Anthem takeover bid
US health insurer Cigna has rebuffed an offer from larger rival Anthem, which made two takeover bids within the last 10 days, The Wall Street Journal reported on Monday citing people familiar with the matter.
Finsbury Food Group completes Johnstone's Just Desserts acqusition
Bakery products manufacturer Finsbury Food Group has completed the acquisition of Johnstone's Just Desserts for an undisclosed amount.
XLMedia snaps up majority stake in Marmar Media
Digital marketing outfit XLMedia said it is planning to buy a majority stake in web and mobile business Marmar Media.
GlaxoSmithKline could reportedly be targeted by Roche, Johnson & Johnson
Pharmaceuticals giant GlaxoSmithKline could reportedly become the latest takeover target in the industry.
Health-care deal activity heats up as Anthem launches second bid for rival
New York-listed health care provider Anthem has launched another takeover bid for rival Cigna.
Aukett Swanke buys 80% stake in architect firm John R Harris & Partners
Aukett Swanke said on Monday that it has acquired an 80% stake in John R Harris & Partners (JRHP) for a total consideration of £897,000 that will be paid in cash and funded from the company’s existing balances.
Mosmon Oil & Gas fails in bid to takeover MEO Australia
Mosmon Oil and Gas said on Monday that it has failed in its bid to takeover MEO Australia after the deadline passed on Friday.
Metro drops after saying it will sell Galeria Kaufhof to Hudson's Bay for EUR2.83bn
Shares in German retailer Metro AG fell 3% on Monday after the company said it is selling its Galeria Kaufhof department stores and its Belgian subsidiary, Inno, to Hudson’s Bay Company for €2. 83bn .
CVS Health to buy Target pharmacy business for $1.9bn
CVS Health unveiled plans to acquire Target Corp’s pharmacy and clinic business for about $1. 9bn.
Enoc ups its offer to seal Dragon Oil deal
Emirates National Oil Company has upped the ante to buy the remainder of Dragon Oil, valued at £1. 7bn.
Aveva said to be working with Lazard on takeover options
Software developer Aveva has reportedly hired bankers Lazard to consider its strategic options as speculation over a bid from an American suitor grows.
Vedanta Resources shares gain on merger confirmation
Shares in Vedanta Resources rose 2. 5% on Monday as investors welcomed the company’s confirmation over the weekend that it is merging Vedanta Ltd and Cairn India.
Orion considering bidding for Tesco's South Korean unit
South Korean snack maker Orion said it was considering bidding for Tesco’s South Korean unit, which is worth approximately £3. 9bn.
Virgin may launch bid for Spain's Yoigo, report says
UK's Virgin group could be looking to acquire mobile telecommunications operator Yoigo from Sweden's TeliaSonera, Spanish economic daily El Economista reported on Friday citing people close to the operation.
KKR, Carlyle said to be among firms invited to bid for Tesco's South Korean unit
Tesco has reportedly invited at least six firms including KKR and Carlyle Group to bid for its South Korean unit Homeplus, which is valued at about $6bn, as the supermarket retailer looks to cut debt and fund a turnaround plan.
Stifel to buy Barclays US wealth business
Stifel Financial Corp announced on Monday that it has entered into a deal to buy Barclays’ wealth and investment management fanchise in the Americas for an undisclosed sum.
Diageo upgraded to 'neutral' by JPMorgan Cazenove
JPMorgan Cazenove upgraded Diageo to ‘neutral’ from ‘underweight’ and raised the target price to 1,900p from 1,700p, noting that the stock is down 4% year-to-date versus the European beverages sector up 10%.